PhD from UNSW and NeuRA - former U Delaware postdoc - teaching at Concordia
Joined May 2016
- Tweets617
- Following868
- Followers151
- Likes8.9K
David Grenet retweeted
You can have a piece of the Wingspan Forest! @tomuaj has made beautiful collages the she’s auctioning to support the @DrNadiaChaudhri Wingspan award! Check out her beautiful art in the thread below!
I am supporting @DrNadiaChaudhri Wingspan Fund by donating collages from my “Wingspan Forest” series to those do donate to the fund and win my donation challenges. I will be posting one collage at a time with a challenge. After 24 hours, I will share the winner. Fist one below.
David Grenet retweeted
The @DrNadiaChaudhri Wingspan Award Shuffle team is now live! Follow the link below to "Join the Team" or "Donate".
advanceconcordia.ca/ui/shuff…
David Grenet retweeted
It's with a heavy heart, and considerable optimism that I ask you to consider donating to the Nadia Chaudhri Wingspan Award and help us continue Nadia's outstanding legacy of supporting underrepresented students in neuroscience:
concordia.ca/alumni-friends/…
David Grenet retweeted
This fund is earmarked for young scholars from backgrounds that are diverse, under-resourced, marginalized or traditionally under-represented in psychological and neural sciences.
Here is the campaign link:
gofund.me/8d52f7d7
David Grenet retweeted
I hereby claim, for NIH funding purposes, a fundable score for my soon-to-be submitted R01 grant proposal.
David Grenet retweeted
You can’t predict that they “don’t want to learn” because they’re laying down or sitting on their beds during class. Much more than predicting thru want to learn when they’re sitting up
David Grenet retweeted
When the Dewey Beach Grotto Pizza sends white smoke up the chimney, we’ll know Biden has chosen a running mate.
David Grenet retweeted
Cilia et al. examine the effects of long-term levodopa on motor disability progression in the overnight OFF-state in #Parkinson's disease. Compared to natural progression, levodopa reduces annual decline in OFF-state UPDRS-III by almost one third. bit.ly/3e1A0hO
David Grenet retweeted
I was wrong. Thanks to all those who offered constructive criticism forbes.com/sites/stevensalzb…
David Grenet retweeted
New vaccines are scarce at first. If we have excess doses, we should expand the size of the randomized trial (or share with other multi-arm trials), not issue compassionate use exceptions that consume scarce vaccine without learning in the process.
This quoted post is unavailable.
David Grenet retweeted
I very much agree with @nataliexdean on this. We cannot skip safety & efficacy testing just because its an emergency. The process can & has been sped up as much as is safe. Anymore & we risk jeopardizing our ability to fight not only COVID, but ALL vaccine-preventable diseases.
David Grenet retweeted
Let’s kickoff #BlackNeuroRollCall by introducing some of the Black neuroscientists, neuro-engineers, and science communicators on our incredible organizing team! 🙌🏾
We are all SO proud to be #BlackInNeuro ✊🏾🧠
David Grenet retweeted
My name is Lietsel (rhymes with diesel) and I am a Mechanical Engineering PhD student at the University of Central Florida. My research focus is in neuromechanics 🧠 ⚙️ I’m from a little island in the Caribbean called Sint Maarten 🇸🇽 and I’ve always wanted to be a scientist.
ALT Graphic designed by abm of Lietsel dancing with a neuron, her black cat reaching for the axon, along with colorful icons of a brain and Lietsel’s blog on a laptop
ALT Photo of Lietsel standing on a Balance Board generating a colorful image on a screen
David Grenet retweeted
We are *thrilled* to introduce the incredible team of organizers bringing you #BlackInNeuroWeek! ✊🏾✊🏽✊🏿✊🏼
Follow them, follow @BlackInNeuro, and get ready for #BlackInNeuroWeek 🧠✨‼️🎉🥳💖🤩
David Grenet retweeted
Ioannidis went on to show in studies that COVID wasn’t risky for most people. You may recall THE antibody study.
In May, when I reported the JetBlue founder had funded that study, Ioannidis claimed to not know who his funders were.
So I found this March email interesting...
